Table 4.

Sensitivity of CA125, afamin, and apoA-IV at cutoffs obtaining specificities 60% to 90% for differentiating ovarian cancer patients from healthy individuals (A) and from individuals with benign disease (B)

CA125
Afamin
ApoA-IV
Specificity (%)Cutoff (units/mL)Sensitivity (%)Cutoff (mg/L)Sensitivity (%)Cutoff (mg/dL)Sensitivity (%)
(A)
    9538.184.045.828.77.229.8
    9024.491.252.741.48.340.3
    8019.095.660.959.110.254.7
    7016.296.165.869.111.265.7
    6014.697.268.475.711.870.2
(B)
    95128.067.444.326.05.214.9
    9082.071.849.133.16.524.9
    8038.783.453.844.28.641.4
    7026.290.157.653.09.752.5
    6019.995.662.061.310.760.2